Biotech Firms Arvinas, Opus Genetics Miss Earnings Estimates

Biotech companies Arvinas and Opus Genetics both reported their latest financial results, with each firm missing analysts' expectations for both GAAP earnings per share and revenue. This indicates a challenging quarter for both companies in their respective financial performances.